Top-News

Five Prime Therapeutics News

Aktie
WKN:  A1W5T9 ISIN:  US33830X1046 US-Symbol:  FPRX
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
36,63 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 17.08.2020

Five Prime Therapeutics News

16.04.21 - PR Newswire
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics
Amgen Successfully Completes Acquisition Of Five Prime Therapeutics PR Newswire
04.04.21 - PR Newswire
Lifshitz Law Firm, P.C. Announces Investigation of ATH, WIFI, BMTC, WSFS, DSSI, INSW, FPRX, FI, HWCC, and RMBL
Lifshitz Law Firm, P.C. Announces Investigation of ATH, WIFI, BMTC, WSFS, DSSI, INSW, FPRX, FI, HWCC, and RMBL PR Newswire
01.04.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds HWCC, FI, SVBI, and FRPX Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds HWCC, FI, SVBI, and FRPX Shareholders About Its Ongoing Investigations PR Newswire
30.03.21 - PR Newswire
Halper Sadeh LLP Investigates the Following Mergers - TPCO, STAY, KSU, CUB, AEGN, FPRX; Shareholders Are Encouraged to Contact the Firm
Halper Sadeh LLP Investigates the Following Mergers - TPCO, STAY, KSU, CUB, AEGN, FPRX; Shareholders Are Encouraged to Contact the Firm PR Newswire
25.03.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and VKIN Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and VKIN Shareholders About Its Ongoing Investigations PR Newswire
18.03.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and PAND Shareholders About Its Ongoing Investigations
SHAREHOLDER ALERT: WeissLaw LLP Reminds FI, SVBI, FRPX, and PAND Shareholders About Its Ongoing Investigations PR Newswire
11.03.21 - PR Newswire
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MGLN, FPRX, FLIR, WDR, HMSY, SNCA; Shareholders are Encouraged to Contact the Firm
INVESTIGATION ALERT: Halper Sadeh LLP Investigates MGLN, FPRX, FLIR, WDR, HMSY, SNCA; Shareholders are Encouraged to Contact the Firm PR Newswire
05.03.21 - PR Newswire
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Five Prime Therapeutics, Inc. - FPRX
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Five Prime Therapeutics, Inc. - FPRX PR Newswire
05.03.21 - PR Newswire
Moore Kuehn Encourages FPRX, SVBI, SOAC, and CAP Investors to Contact Law Firm
Moore Kuehn Encourages FPRX, SVBI, SOAC, and CAP Investors to Contact Law Firm PR Newswire
04.03.21 - PR Newswire
ALERT: Halper Sadeh LLP Investigates SVBI, FPRX, MIK, JCS; Shareholders are Encouraged to Contact the Firm
ALERT: Halper Sadeh LLP Investigates SVBI, FPRX, MIK, JCS; Shareholders are Encouraged to Contact the Firm PR Newswire
04.03.21 - PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.
SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc. PR Newswire
04.03.21 - PR Newswire
Shareholder Alert: Ademi LLP Investigates whether Five Prime Therapeutics has obtained a Fair Price in its transaction with Amgen
Shareholder Alert: Ademi LLP Investigates whether Five Prime Therapeutics has obtained a Fair Price in its transaction with Amgen PR Newswire
04.03.21 - PR Newswire
Should you invest in Nio, Rocket Companies, Carnival Corp, Five Prime Therapeutics, or Burlington Stores?
Should you invest in Nio, Rocket Companies, Carnival Corp, Five Prime Therapeutics, or Burlington Stores? PR Newswire
04.03.21 - Der Aktionär
Amgen schlägt zu: Aktie von Five Prime Therapeutics explodiert
04.03.21 - PR Newswire
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash
Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in Cash Acquisition Includes Bemarituzumab, A Phase 3 Ready, First-​In-Class Program For Gastric Cancer, the Third ...
15.01.21 - PR Newswire
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics?
Thinking about buying stock in Obseva SA, DBV Technologies, BlackBerry, Five Prime Therapeutics, or BioNano Genomics? PR Newswire
05.01.21 - PR Newswire
Thinking about buying stock in Zomedica, Zosano Pharma, TapImmune, Five Prime Therapeutics, or Inuvo?
Thinking about buying stock in Zomedica, Zosano Pharma, TapImmune, Five Prime Therapeutics, or Inuvo? PR Newswire
11.11.20 - PR Newswire
Thinking about buying stock in Five Prime Therapeutics, Ford, Laredo Petroleum, Electrameccanica Vehicles, or Nvidia?
Thinking about buying stock in Five Prime Therapeutics, Ford, Laredo Petroleum, Electrameccanica Vehicles, or Nvidia? PR Newswire
03.04.18 - PR Newswire
Personal Genome Diagnostics Announces Collaboration to Develop Plasma-Based Companion Diagnostic for Five Prime Therapeutics' Targeted Immuno-Oncology Drug Candidate Bemarituzumab
Personal Genome Diagnostics Announces Collaboration to Develop Plasma-​Based Companion Diagnostic for Five Prime Therapeutics' Targeted Immuno-​Oncology Drug ...

Newssuche

Videos

newspaper
03.05.24 -13,45%
Technical Trading: Gold freitags Long
Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »